Chromocell Therapeutics Corp (CHRO)
NYSE MKT:CHRO
US Market
Holding CHRO?
Track your performance easily

Chromocell Therapeutics Corp (CHRO) Ownership - Who Owns Chromocell Therapeutics Corp?

13 Followers

Chromocell Therapeutics Corp (CHRO) Ownership Overview

20.62%0.00%3.49%75.89%
20.62% Insiders
3.49% Other Institutional Investors
75.89% Public Companies and
Individual Investors
The ownership structure of Chromocell Therapeutics Corp (CHRO) stock is a mix of institutional, retail and individual investors. Approximately 3.49% of the company’s stock is owned by Institutional Investors, 20.62% is owned by Insiders and 75.89% is owned by Public Companies and Individual Investors.
The ownership structure of Chromocell Therapeutics Corp (CHRO) stock is a mix of institutional, retail and individual investors. Approximately 3.49% of the company’s stock is owned by Institutional Investors, 20.62% is owned by Insiders and 75.89% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Sep 16, 2024
xxxxxxxxxxxxx
$9776
Sep 16, 2024
Knuettel Francis
Ceo, Pres., Cfo, Treas & Secty
xxxxxxxxxxxxx
$5044
Sep 12, 2024
Knuettel Francis
Ceo, Pres., Cfo, Treas & Secty
xxxxxxxxxxxxx
$10955

Top Shareholders

Holder
# of Shares
Type
% Holding
Value

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value

FAQ

Who Owns Chromocell Therapeutics Corp (CHRO)?
According to the latest TipRanks data, approximately 3.49% of the company's stock is held by institutional investors, 20.62% is held by insiders, and 75.89% is held by retail investors.
    What percentage of Chromocell Therapeutics Corp (CHRO) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 3.49% of Chromocell Therapeutics Corp (CHRO) stock is held by institutional investors.
      What percentage of Chromocell Therapeutics Corp (CHRO) stock is held by retail investors?
      According to the latest TipRanks data, approximately 75.89% of Chromocell Therapeutics Corp (CHRO) stock is held by retail investors.
        Who owns the most shares of Chromocell Therapeutics Corp (CHRO)?
        Currently, no data Available
        What is the significance of the ownership structure for a publicly traded company?
        The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis